Skip to content

A Study on Ayurvedic Treatment for Ardhavbhedaka (Migraine) Using Laghu Sutshekhar Ras, Anu Taila Nasya and Pathyadi Kwath

A Single Arm Open Label Clinical Study to Evaluate the Efficacy of Laghu Sutshekhar Ras and Anu Taila Nasya along with Pathyadi Kwath in the Management of Ardhavbhedaka (Migraine) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096912
Enrollment
30
Registered
2025-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Institute for Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptoms of Ardhavabhedaka (Migraine with or without aura) will be selected irrespective of Sex, Religion and Profession. Patients those are fit for Nasya Karma according to Ayurveda text. Patients who have given written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Age group less than 18 years and more than 50 years. The patient having any systemic illness, like - Diabetes mellitus, Hypertension, Tuberculosis, Hypotension & fever etc. Patients suffering from head injury, and other type of headaches except migraine. Patients Contraindicated for Nasya Karma. Patients unwilling to provide written consent for participation are excluded. Pregnant and lactating mothers. Secondary headache caused by sinusitis, meningitis, brain tumour, encephalitis, cervical spondylitis etc. Patients with any inflammatory disease. Patients requiring surgical treatment (eg- for nasal polyp). Patients with alcohol, opioids other drug addiction and using any other systemic drugs which may alter the result of study.

Design outcomes

Primary

MeasureTime frame
Significant improvement in signs and symptoms of Ardhavbhedaka (Migraine). Timepoint: Follow up of patient will be done on 15th, 35th day of the treatment.

Secondary

MeasureTime frame
Improvement in mental & physical well being of patient.Timepoint: Follow up on 15th , 30th day after treatment .

Countries

India

Contacts

Public ContactDr Vandana Saini

Institute for Ayurved Studies and Research Kurukshetra Haryana

drmanojtanwar23@gmail.com9996310888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026